全文获取类型
收费全文 | 28721篇 |
免费 | 2152篇 |
国内免费 | 218篇 |
专业分类
耳鼻咽喉 | 394篇 |
儿科学 | 671篇 |
妇产科学 | 888篇 |
基础医学 | 3559篇 |
口腔科学 | 410篇 |
临床医学 | 3099篇 |
内科学 | 6377篇 |
皮肤病学 | 576篇 |
神经病学 | 2184篇 |
特种医学 | 934篇 |
外科学 | 4992篇 |
综合类 | 580篇 |
现状与发展 | 2篇 |
一般理论 | 19篇 |
预防医学 | 1732篇 |
眼科学 | 567篇 |
药学 | 1862篇 |
中国医学 | 112篇 |
肿瘤学 | 2133篇 |
出版年
2023年 | 249篇 |
2022年 | 214篇 |
2021年 | 1201篇 |
2020年 | 624篇 |
2019年 | 922篇 |
2018年 | 1131篇 |
2017年 | 748篇 |
2016年 | 783篇 |
2015年 | 1017篇 |
2014年 | 1374篇 |
2013年 | 1589篇 |
2012年 | 2439篇 |
2011年 | 2404篇 |
2010年 | 1388篇 |
2009年 | 1142篇 |
2008年 | 1800篇 |
2007年 | 1742篇 |
2006年 | 1525篇 |
2005年 | 1441篇 |
2004年 | 1240篇 |
2003年 | 1041篇 |
2002年 | 898篇 |
2001年 | 522篇 |
2000年 | 452篇 |
1999年 | 392篇 |
1998年 | 179篇 |
1997年 | 139篇 |
1996年 | 98篇 |
1995年 | 86篇 |
1994年 | 85篇 |
1993年 | 66篇 |
1992年 | 196篇 |
1991年 | 191篇 |
1990年 | 165篇 |
1989年 | 143篇 |
1988年 | 126篇 |
1987年 | 141篇 |
1986年 | 117篇 |
1985年 | 106篇 |
1984年 | 88篇 |
1983年 | 66篇 |
1981年 | 51篇 |
1980年 | 52篇 |
1979年 | 79篇 |
1978年 | 66篇 |
1977年 | 46篇 |
1976年 | 51篇 |
1975年 | 44篇 |
1974年 | 53篇 |
1972年 | 60篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
Joshua J. Bear Heidi E. Kirsch Brian D. Berman Kevin E. Chapman Jason R. Tregellas 《Epileptic Disord》2020,22(3):291-299
Aims. Functional connectivity is providing new insights into the network nature of epilepsy with growing clinical applications. Our objective was to validate a novel magnetoencephalography‐based method to non‐invasively measure the epileptic network. Methods. We retrospectively identified pediatric and adult patients with refractory focal epilepsy who underwent pre‐surgical magnetoencephalography with subsequent intracranial electrographic monitoring. Magnetoencephalography tracings were visually reviewed, and interictal epileptiform discharges (“spikes”) were individually marked. We then evaluated differences in whole‐brain connectivity during brief epochs preceding the spikes and during the spikes using the Network‐Based Statistic to test differences at the network level. Results. In six patients with statistically‐significant network differences, we observed substantial overlap between the spike‐associated networks and electrographically active areas identified during intracranial monitoring (the spike‐associated network was 78% and 83% sensitive for intracranial electroencephalography‐defined regions in the irritative and seizure onset zones, respectively). Conclusion. These findings support the neurobiological validity of the spike‐associated network method. Assessment of spike‐associated networks has the potential to improve surgical planning in epilepsy surgery patients by identifying components of the epileptic network prior to implantation. 相似文献
6.
7.
8.
Anuj Shrestha Zeeshan Jawa Kathryn L. Koch Amy B. Rankin Qun Xiang Anand Padmanabhan Matthew S. Karafin Joshua J. Field 《Journal of clinical apheresis》2015,30(6):353-358
Red cell exchange (RCE) is a common procedure in adults with sickle cell disease (SCD). Implantable dual lumen Vortex (DLV) ports can be used for RCE in patients with poor peripheral venous access. We performed a retrospective cohort study of RCE procedures performed in adults with SCD. The main objective of the study was to compare the inlet speed, duration of procedures and rate of complications performed through DLV ports to those performed through temporary central venous and peripheral catheters. Twenty‐nine adults with SCD underwent a total of 318 RCE procedures. Twenty adults had DLV ports placed and 218 procedures were performed using DLV ports. Mean length of follow‐up after DLV port placement was 397 ± 263 days. Six DLV ports were removed due to infection and 1 for malfunction after a mean of 171 ± 120 days. Compared to temporary central venous and peripheral catheters, DLV port procedures had a greater rate of procedural complications, a longer duration, and a lower inlet speed (all P < 0.01). When accounting for the maximum allowable inlet speed to avoid citrate toxicity, 40% of DLV port procedures were greater than 10% below maximum speed, compared to 7 and 14% of procedures performed through temporary central venous and peripheral catheters (P < 0.0001). In conclusion, DLV ports can be used for RCE in adults with SCD, albeit with more procedural complications and longer duration. The smaller internal diameter and longer catheter of DLV ports compared to temporary central venous catheters likely accounts for the differences noted. J. Clin. Apheresis 30:353–358, 2015. © 2015 Wiley Periodicals, Inc. 相似文献
9.
10.
Chih-Wei Hsu Sheng-Yu Lee Yao-Hsu Yang Liang-Jen Wang 《The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)》2020,23(10):653
BackgroundGeneric antidepressants are approved on the market based on evidence of bioequivalence to their brand-name versions. We aimed to assess whether generic antidepressants exert equal effectiveness as their brand-name counterparts for treating patients with depressive disorders.MethodsIn a nationwide, population-based cohort in Taiwan from 1997 through 2013, patients with a diagnosis of a depressive disorder aged between 18 and 65 years who were new users of antidepressant drugs were classified into either the brand-name group or the generic group. All patients were followed up until medication discontinuation or the end of the study period. We assessed the risk for hospitalization as a primary outcome and augmentation therapy, daily dose, medication discontinuation, or switching to another antidepressant as secondary outcomes.ResultsA total of 277 651 brand-name users (35.8% male; mean age: 41.2 years) and 270 583 generic users (35.8% male; mean age: 41.0 years) were divided into 10 different antidepressant groups (fluoxetine, sertraline, paroxetine, escitalopram, citalopram, venlafaxine, mirtazapine, moclobemide, imipramine, and bupropion). We found that patients treated with the generic form of sertraline, paroxetine, escitalopram, venlafaxine, mirtazapine, and bupropion demonstrated significantly higher risks of psychiatric hospitalization (adjusted hazard ratios ranged from 1.20–2.34), compared to their brand-name counterparts. The differences between brand-name antidepressants and their generic counterparts in secondary outcomes varied across different drugs.ConclusionsCompared to most generic antidepressants, brand-name drugs exhibited more protective effects on psychiatric hospitalization for depressive patients. These findings could serve as an important reference for clinicians when encountering patients with depressive disorder. 相似文献